M. Lahutte

Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria

Jaime Gállego Pérez‐Larraya, M. Lahutte, Grégorio Petrirena et al. · Neuro-Oncology · 2012 · 104 citations · Full text

High-grade Gliomas, Recurrent Glioblastoma, Response Assessment +18

Severe meningo-radiculo-nevritis associated with ipilimumab

Flavie Bompaire, Christine Mateus, H. Taillia et al. · Investigational New Drugs · 2012 · 67 citations

Rheumatology, Autoimmune Disease, Vasculitis +5

Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression

Germán Reyes-Botero, Caroline Dehais, Ahmed Idbaïh et al. · Neuro-Oncology · 2013 · 67 citations · Full text

Evaluation of Quantitative Criteria for Glioma Grading With Static and Dynamic 18F-FDopa PET/CT

Christophe Nioche, M. Soret, É. Gontier et al. · Clinical Nuclear Medicine · 2013 · 36 citations

New insights in radiation-induced leukoencephalopathy: a prospective cross-sectional study

Flavie Bompaire, M. Lahutte, Stéphane Buffat et al. · Supportive Care in Cancer · 2018 · 32 citations

Engineering, Radiation Effect, Hematology +8